GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Ganciclovir

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Original oral ganciclovir schedules are not oral valganciclovir schedules. The source grouping of HD and PD is preserved and flagged for modality-specific revalidation.

Check source scope before reading a dose

Cytovene-IV - labeled renal guidance

Product / population
Ganciclovir (Cytovene-IV), adult IV induction or maintenance for labeled CMV indications
Renal method
Cockcroft-Gault creatinine clearance, mL/min
Source revision
Prescribing information revised 07/2017
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Cytovene-IV - product and source limitations

Infuse over one hour. Check CrCl and blood counts. The label's nondialysis table separates induction from maintenance; dosing below CrCl 10 without HD is not supplied by the HD row.

What to reconcile: Verify the current prescribing information for this presentation.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Cytovene-IV - labeled renal guidance

Open original reference

FDA / product prescribing information · Ganciclovir (Cytovene-IV), adult IV induction or maintenance for labeled CMV indications

Renal method: Cockcroft-Gault creatinine clearance, mL/min
Source date: Prescribing information revised 07/2017
Retrieved: 2026-11-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Dialysis evidence: A regimen is reported in selected content

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 2, adult renal dosage table and hemodialysis

Limits that apply to these rows

Infuse over one hour. Check CrCl and blood counts. The label's nondialysis table separates induction from maintenance; dosing below CrCl 10 without HD is not supplied by the HD row.

Adult renal dosing in this source
Adult CrCl (mL/min)Induction, IV over 1 hourMaintenance, IV over 1 hour
50-692.5 mg/kg every 12 hours2.5 mg/kg every 24 hours
25-492.5 mg/kg every 24 hours1.25 mg/kg every 24 hours
10-241.25 mg/kg every 24 hours0.625 mg/kg every 24 hours
<10, on HD1.25 mg/kg after HD, 3 times weekly0.625 mg/kg after HD, 3 times weekly
Read the retained text before reformatting

For adult intermittent hemodialysis (HD), induction must not exceed 1.25 mg/kg IV after HD three times weekly. Maintenance must not exceed 0.625 mg/kg IV after HD three times weekly. At CrCl 50-69, induction is 2.5 mg/kg every 12 hours and maintenance 2.5 mg/kg daily; at 25-49, use 2.5 and 1.25 mg/kg daily, respectively; at 10-24, use 1.25 and 0.625 mg/kg daily. Infuse over one hour. Check CrCl and blood counts. The label's nondialysis table separates induction from maintenance; dosing below CrCl 10 without HD is not supplied by the HD row.

RDM73-cytovene-official-1 · Source locator: Renal guidance: 2, adult renal dosage table and hemodialysis

Source identity and provenance
Source family
product_label
Source
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019661s036lbl.pdf
Retrieved
2026-11-07
Renal-function method
Cockcroft-Gault creatinine clearance, mL/min
Source date/version
Prescribing information revised 07/2017
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
e3622966fe32c2b7fbe14faf2aa97fb5e6ab4fec4c41b3e450ec2be9438554a7

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ganciclovir&s1=RDM73-cytovene-official&h1=91402fb9e261315b57dfa4abd885e61ad3308413c968dd95cf7435e71fab84ed

Top